Citations

Clear

4207 citation(s) found for "Chen, Yu".

Generative diffusion model enables quantification of calibration‐free arterial spin labeling perfusion magnetic resonance imaging data in an Alzheimer's disease cohort
Shou, Qinyang , Ringman, John M. , Kim, Hosung , Jack, Clifford R. , Borowski, Bret, Arani, Arvin , Wang, Danny J.J. , Initiative, and for the Alzheimer's Disease Neuroimaging, Borowski, Bret J, Wang, Danny J J , Jack, Clifford R , Arani, Arvin , Cen, Steven , Chen, Nan‐kuei , Senjem, Matthew L. , Initiative, and for the Alzheimer's Disease Neuroimaging

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | October 30, 2025 | Volume: 17 | Issue: 4 | Pages: No page available

10.1002/dad2.70214 | PMID 41181519 Get It

Abstract INTRODUCTION M0 images were missing in Siemens ASL data in Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset, prohibiting cerebral blood flow (CBF) quantification. METHODS A conditional latent diffusion model was trained and evaluated on in‐house datasets, then applied to the Siemens data in ADNI‐3. Regional CBF differences by Alzheimer's disease (AD) stages, their accuracy for AD classification, and CBF trajectory slopes were compared between generated data (Siemens) and acquired data (General Electric). RESULTS The diffusion model generated M0 images with high fidelity (SSIM = 0.918 ± 0.023, PSNR = 31.361 ± 2.537) and minimal CBF bias (mean difference is 0.21 ± 1.58 mL/100 g/min). Both generated and acquired CBF showed similar spatial patterns and decreasing trends with AD progression in specific AD‐related regions. Generated CBF also improved accuracy in classifying AD stages compared to qualitative perfusion images. CONCLUSION This study shows the potential of diffusion models for imputing missing modalities in large‐scale studies exploring the use of ASL as a biomarker of AD. Highlights Using latent diffusion model, we can generate M0 image from control image in arterial spin labeling (ASL) with high fidelity. The generated M0 can be used for cerebral blood flow (CBF) quantification in Alzheimer's Disease Neuroimaging Initiative dataset. The performance of classification between Alzheimer's disease (AD) patients and cognitive normal people is better when using generated CBF maps than using non‐quantitative perfusion images. ASL CBF decreases with AD progression in key AD‐related brain regions.
Spatial multiomics of human hepatic lymph nodes reveals early APC bifurcation in liver transplant rejection
Nguyen, Justin H. , Ashraf, Humza, Moore, Raymond M. , Sherman, William H., Ma, Yaohua , Embretsen, Mattias , Cogen, Davitte , Kachergus, Jennifer M., Thompson, Cheryl L. , Killeen, Heather, Nakhleh, Raouf E. , Thompson, E. Aubrey , Knutson, Keith L. , Ashraf, Humza, Sherman, William, Thompson, Cheryl, Killeen, Heather E., Wang, Chen , Markovic, Svetomir N. , Knutson, Keith L.

Mayo Clinic

No container title available | October 28, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7901096/v1 Get It

Abstract The highest risk for liver allograft rejection is within the first weeks to months after a liver transplant; however, while later-stage mechanisms are well described, the initial window at the moment of alloantigen influx (e.g., ~ 1 h post-reperfusion) remains unmapped. T-cell priming is initiated in lymph nodes, yet these sites are rarely profiled in humans and their relationship to rejection risk is unclear. To address this gap, we profiled paired pre- and ~ 1 h post-reperfusion hepatic draining lymph nodes from liver transplant recipients using multiplexed immunofluorescence and GeoMx whole-transcriptome profiling to identify features that predict rejection versus non-rejection. Early after reperfusion, CD4 + and CD8 + T cells became proximal to macrophages in rejection compared to dendritic cells in non-rejection, which also displayed an immunoregulatory-leaning profile marked by PD-1, IDO1, and CD39, suggesting that macrophages and dendritic cells differentially influence early T-cell alloimmunity. These results provide nodal targets for precise immune modulation.
Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis
Wixner, Jonas, Conceição, Isabel , Adams, David , Polydefkis, Michael , Gillmore, Julian D., Dyck, P. James B. , Chen, Jersey , Kwoh, T. Jesse, Nåtman, Jonatan , Zhou, Wunan , Adams, David , Gillmore, Julian D , Conceição, Isabel , Berk, John L. , Attarian, Shahram , Gillmore, Julian D. , Waddington‐Cruz, Márcia

Mayo Clinic

Amyloid | October 28, 2025 | Volume: 33 | Issue: 1 | Pages: 85-89

10.1080/13506129.2025.2577361 | PMID 41147681 Get It

Faculty Utilization of X (Formerly: Twitter): What, Why, and How Many
Akhund, Ramsha , Lanka, Santh Prakash , Allahwasaya, Ashba , Saleeb, Andrew G. , Fazendin, Jessica , Saleeb, Andrew G , McLeod, Chandler , Gillis, Andrea , Chen, Herbert , Liu, Jessica

Mayo Clinic

The American Surgeon™ | October 24, 2025 | Volume: 92 | Issue: 4 | Pages: 1206-1213

10.1177/00031348251388955 | PMID 41133845 Get It

Introduction Social media platforms, particularly X (formerly Twitter), play an influential role in professional networking and information dissemination. This study aimed to examine X usage trends among faculty in a single department of surgery at a large academic institution. Methods Faculty X accounts were analyzed from January to June 2022. Metrics such as follower count, number of accounts followed, and post (formerly: tweets) types (original/quoted reposts) were studied. Themes of posts were categorized as personal, promotional, educational, or related to academic events/conferences. Associations between faculty rank, division, gender, and post metrics were explored using Mann-Whitney U and Kruskal-Wallis tests. Results Of 133 faculty members, 53 (39.85%) had X accounts, with 3 excluded due to privacy settings. A total of 3476 posts were analyzed, averaging 0-34 posts/month per faculty. Categories included professional (63%, n = 2174), educational (19%, n = 653), and personal (13%, n = 436). No significant associations were found between faculty gender/division and posting rates. However, faculty rank correlated significantly with primary post categories ( P < 0.01). Associate professors, and professors posted more about academic events (2% and 1%) than instructors or assistant professors (1%). The most followed faculty actively promoted colleagues’ work through reposting. Conclusion Less than half the faculty in a single department of surgery engaged with X. Those active predominantly used it for promotion, followed by education and personal use. Adoption remains limited, highlighting opportunities for growth in utilizing X for academic dissemination.
3498 Non-invasive neuromodulation for the treatment of drug-resistant epilepsy: systematic review and meta-analysis investigating efficacy, safety, and optimal stimulation parameters
Premaratne, Sayumi , Hamer, Ryan P. , O’Brien, Terry, Zoghi, Maryam , Antonic‐Baker, Ana , Chen, Zhibin ZC , Chen, Leo , Major, Brendan P. , Thomas, Elizabeth H. X. , Kwan, Patrick , O’Brien, Terry, Lundstrom, Brian N. , Simpson, Hugh D.

Mayo Clinic

Poster Abstracts | October 24, 2025 | Volume: No volume available | Issue: No issue available | Pages: A27.2-A27

10.1136/bmjno-2025-anzan.72 Get It

SAT-405 TSH testing patterns for patients with type 2 diabetes and hypothyroidism after GLP-1 RA initiation in a target trial setting
Ospina, Naykky Singh , Chen, Yi-Shan , Du, Fanxing , Brito, Juan P. , Shao, Hui , Liu, Qing , McCoy, Rozalina G. , Jiao, Tianze

Mayo Clinic

Journal of the Endocrine Society | October 23, 2025 | Volume: 9 | Issue: Supplement_1 | Pages: No page available

10.1210/jendso/bvaf149.2320 Get It

Abstract Disclosure: N.M. Singh Ospina: None. Y. Chen: None. F. Du: None. J.P. Brito: None. H. Shao: None. Q. Liu: None. R.G. McCoy: None. T. Jiao: None. Background: The levothyroxine dose for patients with hypothyroidism is highly correlated with weight. In patients with hypothyroidism, TSH measurements are used to assess the adequacy of levothyroxine dosing.Since type 2 diabetes (T2D) and obesity are two common comorbidities for patients with hypothyroidism, and the significant weight loss associated with Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) therapy, the initiation of GLP-1 RA on levothyroxine users may significant increase the need for levothyroxine dose reduction potentially requiring additional TSH tests to assure control. Objectives: To evaluate the timing and frequency of TSH testing within one year of initiation of GLP-1, or sodium-glucose co-transporter 2 (SGLT-2) inhibitors, in patients with T2D on levothyroxine treatment. Methods: We identified a cohort of T2D patients using 15% of Medicare fee-for-service claims data from 2005 to 2020. Cohort entry was defined by the initiation of GLP-1 or SGLT2. Patients needed to continuously receive the same dose of levothyroxine for &gt;6 months and have at least 1 TSH measurement before the index date. We excluded patients with hyperthyroidism, thyroid cancer, end-stage renal disease, HIV/AIDs, organ transplant, or who received medications that affect thyroid levels before the index date. The primary outcome was the timing and frequency of TSH testing within one year after GLP-1 RA initiation. Demographics, comorbidities, and medication use were balanced using 1:1 propensity score matching based on the index date. Results: After matching, no significant demographic differences were observed among the 2,107 patients in GLP-1 RA and SGLT-2 groups, respectively. Overall, 32.1%, 32.3%, and 35.6% were aged 65-70, 70-74, and over 75, with 69.3% female and 87.9% white. In the year before the index date, the average number of TSH tests was higher in the GLP-1 RA (1.16 ± 1.27) compared to the SGLT2 (1.07 ± 1.18, p-value: 0.001). In the year after the index date, the average number of TSH tests declined to 0.93 ± 1.18 for GLP-1 and 0.89 ± 1.13 for SGLT2 (p-value: 0.03). Most patients (48.6 vs. 49.5%) had no TSH tests, 41.3 vs. 40.6% had 1-2 tests, and 10.1 vs. 9.9% had more than 2 tests in the GLP-1 RA and SGLT-2 group, respectively. Fewer patients (32.3 vs. 33.6%) were tested within 0-6 months while the majority (67.7 vs. 66.5%) waited longer than 6 months. The relative risk of TSH testing between the GLP-1 RA group and the SGLT2 group was 1.03 (95% CI: 0.98 to 1.08) 1-year before the index date and 1.00 (95% CI: 0.94 to 1.06) 1-year after the index date. Conclusions: Despite the potential impact of GLP-1 RA on levothyroxine dosing, on average, half of patients did not receive a TSH test after treatment initiation. There were no significant differences in TSH testing patterns between GLP-1 and SGLT2 groups, with similar test frequencies and timing observed. Presentation: Saturday, July 12, 2025
The Coronal Plane Alignment of the Knee Classification
Grant, Samuel , Graaf, Victor A. van de , Pagnano, Mark W. , Bellemans, Johan , MacDessi, Samuel J. , van de Graaf, Victor A , Pagnano, Mark W , Bellemans, Johan , Macdessi, Samuel , Chen, Dar‐Ren

Mayo Clinic

JBJS Open Access | October 22, 2025 | Volume: 10 | Issue: 4 | Pages: No page available

10.2106/jbjs.oa.25.00165 | PMID 41112702 Get It

Abstract » The coronal plane alignment of the knee (CPAK) classification is a practical and straightforward framework to define a patient’s constitutional coronal knee limb alignment and joint line obliquity. » Patients are assigned to one of nine phenotypes using two straightforward calculations; the arithmetic hip-knee-ankle angle (aHKA) and the arithmetic joint line obliquity (aJLO). » CPAK allows clear understanding of the geographical and gender variations in knee alignment, as well as the differing outcomes of knee reconstructive surgery, based on phenotype. » CPAK enables surgeons to tailor their alignment strategy to best fit a patient’s constitutional phenotype and avoid the drawbacks of a “one-size fits all” approach.
Standalone Endovascular Embolization versus Stereotactic Radiosurgery in the Treatment of Arteriovenous Malformations in Eloquent Brain
Musmar, Basel , Abdalrazeq, Hammam , Adeeb, Nimer , Salim, Hamza , Roy, Joanna M. , Aslan, Assala , Tjoumakaris, Stavropoula I., Ogilvy, Christopher S. , Başkaya, Mustafa K. , Kondziolka, Douglas, Sheehan, Jason P. , Riina, Howard A. , Abushehab, Abdallah, Naamani, Kareem El, Ironside, Natasha , Gummadi, Sanjeev, Ataoglu, Cagdas , Muram, Sandeep , Sconzo, Daniel , Rezai, Arwin, Alwakaa, Omar , Park, Min S. , Hanalıoğlu, Şahin , Erginoğlu, Ufuk , Sen, Rajeev , Burkhardt, Jan‐Karl , Starke, Robert M. , Sekhar, Laligam N., Altschul, David , Haranhalli, Neil , McAvoy, Malia , Zeineddine, Hussein A. , Atallah, Elias , Rosenwasser, Robert H. , Stapleton, Christopher J. , Koch, Matthew J. , Srinivasan, Visish M. , Bulsara, Ketan R., Kim, Louis J. , Pukenas, Bryan, Smith, Edward R. , Alaraj, Ali , Patel, Aman B. , Notarianni, Christina , Lawton, Michael, Guthikonda, Bharat , Salim, Hamza , Riina, Howard , Dmytriw, Adam A , Gummadi, Sanjeev , Ataoglu, Cagdas , Essibayi, Muhammed Amir , Keles, Abdullah , Muram, Sandeep , Alwakaa, Omar , Mantziaris, Georgios , Park, Min S , Hanalioglu, Sahin , Erginoglu, Ufuk , Pöppe, Johannes , Griessenauer, Christoph J , Starke, Robert M , Levitt, Michael R , Altschul, David J , Haranhalli, Neil , Zeineddine, Hussein A , Atallah, Elias , Stapleton, Christopher , Koch, Matthew J , Srinivasan, Visish M , Chen, Peng R , Blackburn, Spiros , Bulsara, Ketan , Choudhri, Omar , Pukenas, Bryan , Smith, Edward , Alaraj, Ali , Patel, Aman B , Notarianni, Christina , Jabbour, Pascal , Musmar, Basel , Ogilvy, Christopher S , Tjoumakaris, Stavropoula , Kandregula, Sandeep , Dmytriw, Adam A. , Naamani, Kareem El , Abdelsalam, Ahmed , Kumbhare, Deepak , Essibayi, Muhammed Amir , Keleş, Abdullah , Tos, Salem M , Mantziaris, Georgios , Sen, Rajeev D., Griessenauer, Christoph J. , Sekhar, Laligam N. , Levitt, Michael R. , Abla, Adib A. , Gooch, Michael Reid , Kim, Louis J. , Choudhri, Omar , Pukenas, Bryan , Mosimann, Pascal J , Aziz‐Sultan, Mohammad Ali , Savardekar, Amey Rajan , Cuellar, Hugo , Morcos, Jacques J. , Jabbour, Pascal

Mayo Clinic

Radiology | October 21, 2025 | Volume: 317 | Issue: 1 | Pages: No page available

10.1148/radiol.250329 | PMID 41117652 Get It

Stereotactic radiosurgery was associated with a higher obliteration rate compared with embolization in patients with eloquent brain arteriovenous malformations, whereas there was no evidence of a difference in functional outcomes or complications after adjustment.
The chromatin regulator HELLS mediates SSB repair and responses to DNA alkylation damage
Joseph, Joyous T. , Wright, Christine, Shibata, Etsuko, Khan, Asad Ullah , Neidigk, Jason S Romero, Chen, Bo-Ruei , Tufail, Saba, Mujawar, Aaiyas , Decker, Olivia, Kadali, Krishna Reethika, Imtiaz, Azait, Jones, Brianna A, Zhang, Yanfeng , Gradilone, Sergio A. , Lewis, Zachary , Sen, Arko , Dutta, Anindya , Czaja, Wioletta , Dutta, Anindya , Czaja, Wioletta , Gradilone, Sergio A , Peixoto, Estanislao , Li, Yong , Neidigk, Jason Romero , Imtiaz, Azait, Jones, Brianna A, Lewis, Zachary , Contreras-Galindo, Rafael

Mayo Clinic

Nucleic Acids Research | October 21, 2025 | Volume: 53 | Issue: 22 | Pages: No page available

10.1093/nar/gkaf1201 | PMID 41297801 Get It

Abstract The SNF2 family chromatin remodeler HELLS has emerged as an important regulator of cell proliferation, genome stability, and several cancer pathways. Significant upregulation of HELLS has been reported in 33 human cancer types. While HELLS has been implicated in DNA damage response, its function in DNA repair is poorly understood. Here, we report a new regulatory link between HELLS and single-strand break (SSB) repair in cellular responses to DNA alkylation damage. We found that loss of HELLS impairs SSB repair and selectively sensitizes cells to DNA alkylating agents and PARP inhibitors (PARPi). Our data reveal non-epistatic interactions between HELLS and PARP1 and suggest that HELLS functionally compensates for PARP1 deficiency in promoting cell survival in response to DNA alkylation damage. Furthermore, we found that HELLS is co-expressed with PARP1 in cancer cells, and its loss is synthetic lethal with homologous recombination deficiency (HRD). This work unveils new functions of HELLS in modulating SSB repair and responses to clinically relevant DNA alkylation damage, thus offering new insights into the potential therapeutic value of targeting HELLS in cancer.
Enhanced Contrast-Free in vivo 3D Ultrasound Microvessel Imaging using Hadamard Multipulse Diverging Wave Transmission and Denoising with a 32×32 Matrix array
Zhang, Jingke , Huang, Lijie , Yin, Jingyi , Chen, Shigao , Zhang, Jingke , Lok, U‐Wai , Huang, Chengwu , DeRuiter, Ryan M.

Mayo Clinic

2025 IEEE International Ultrasonics Symposium (IUS) | October 20, 2025 | Volume: No volume available | Issue: No issue available | Pages: 1-4

10.1109/ius62464.2025.11201304 Get It